Robin Kral

Corporate Officer/Principal bei REATA PHARMACEUTICALS, INC.

Consumer Services

Health Technology

Aktive Positionen von Robin Kral

Unternehmen	Position	Beginn	Ende
REATA PHARMACEUTICALS, INC.	Corporate Officer/Principal	01.01.2004	-

Unternehmen	Position	Beginn	Ende
The University of Texas Southwestern Medical Center	Corporate Officer/Principal	-	-
NPS PHARMACEUTICALS, INC.	Corporate Officer/Principal	-	-

Texas Tech University	Graduate Degree
David Eccles School of Business	Masters Business Admin

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	3
Graduate Degree	1
Undergraduate Degree	1

Sektoral

Consumer Services	4
Health Technology	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	2
Reata Pharmaceuticals, Inc. Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX.	Health Technology
NPS Pharmaceuticals, Inc. NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ.	Health Technology

Private Unternehmen

Health Technology